Navigation Links
FREEDOM-M Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint
Date:6/6/2011

gement on a one-hour conference call to answer questions related to FREEDOM-M.

The conference call is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the conference call will be available for two weeks and can be accessed by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using conference code: 72976350.

This conference call is also being webcast and can be accessed via our website at http://ir.unither.com/events.cfm.

About Tyvaso (treprostinil) Inhalation Solution

Indication

Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%).

The effects diminish over the minimum recommended dosing interval of 4 hours; treatment timing can be adjusted for planned activities.

While there are long-term data on use of treprostinil by other routes of administration, nearly all controlled clinical experience with inhaled treprostinil has been on a background of bosentan (an endothelin receptor antagonist) or sildenafil (a phosphodiesterase type 5 inhibitor).  The controlled clinical experience was limited to 12 weeks in duration.

Important Safety Information

  • TYVASO is intended for oral inhalation only. TYVASO is approved for use only with the TYVASO Inhalation System.
  • The safety and efficacy of TYVASO have not been established in patients with significant underlying lung disease (such as asthma or chronic obstructive pulmonary disease) and in patients under 18 years of age.  Patients with acute pulmona
    '/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... CAMBRIDGE, Mass. , May 1, 2015  Portal ... innovative drug delivery systems, announced today that Robert ... Hunter , Ph.D., University of Auckland Distinguished Professor have ... are thrilled to welcome two esteemed biotechnology leaders, Professor ... , to our team," said Dr. Patrick Anquetil ...
(Date:5/1/2015)... PLEASANTON, Calif. , May 1, 2015  Thoratec Corporation ... support therapies to save, support and restore failing hearts, announced ... the newly created role of President, International. This ... all Thoratec commercial operations outside of North America ... Asia , and Latin America , ...
(Date:5/1/2015)... N.J. , May 1, 2015 /PRNewswire/ ... has expanded its current therapeutic focus beyond ... other serious psychiatric disorders. Braeburn has acquired ... (or second-generation) antipsychotic risperidone for treatment of ... acquisition Braeburn acquires global rights to other ...
Breaking Medicine Technology:Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4
... , SAN DIEGO, Dec. 14 Cardium Therapeutics (NYSE ... Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," ... held December 10-13, 2009 in St. Thomas, U.S. Virgin Islands. ... renowned researchers in the field of advanced wound healing. ...
... , BERKELEY HEIGHTS, N.J., ... ), a worldwide provider of secure Health Information Exchange ... of the Carolinas ("HCC"), a home health agency, and ... have selected Authentidate,s Inscrybe® Healthcare web-based service to streamline ...
Cached Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4
(Date:5/2/2015)... May 02, 2015 As a ... issues of the face, neck and décolleté, radiofrequency ... with real potential for the success of vulvovaginal ... ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical ... ACGE, concluded that ThermiGyn’s temperature controlled radio frequency, ...
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... The Workgroup for Electronic Data ... the use of health IT to create efficiencies in ... to the United States Government Accountability Office (GAO) for ... in Medicare. The report, “ Potential Uses of Electronically ... to the public on Apr. 24, 2015 and examines ...
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 As the ... approaches its 18-month anniversary, many people in the industry ... achieved. , According the latest annual report by ... 74 percent in 2014, and reached nearly $3 billion ... decades-long love affair with cannabis, combined with the ongoing ...
Breaking Medicine News(10 mins):Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3
... overdose deaths declined dramatically after the establishment of North ... according to the findings of a groundbreaking new study ... In the first peer-reviewed study to assess the impact ... a 35% reduction in overdose deaths in the immediate ...
... By Maureen Salamon HealthDay Reporter , ... believe size matters -- and that their penises don,t ... non-surgical penile lengthening treatments, a new study analysis by ... out unproven and potentially dangerous ways of lengthening the ...
... to a new study, severely obese adolescents are no more ... study, which has been released online in the Journal ... be somewhat more vulnerable to psychological effects of obesity. ... for Child and Adolescent Health Policy at MassGeneral Hospital for ...
... , THURSDAY, April 21 (HealthDay News) -- Long-term use of ... as eczema doesn,t cause any major negative side effects, according ... the use of corticosteroid creams or lotions applied to the ... children, the researchers explained. The most common fear among parents ...
... HealthDay Reporter , THURSDAY, April 21 (HealthDay News) -- ... a class of pesticides widely used on food crops and ... noticeable in kids from a California farming region where they ... their use on local crops. The pesticides ...
... mindfulness meditation on pain and working memory may result ... wave called the alpha rhythm. This rhythm is thought ... suggests that a key value of meditation may be ... from Massachusetts General Hospital (MGH), Harvard Medical School and ...
Cached Medicine News:Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 3Health News:Severe obesity not seen to increase risk of depression in teens 2Health News:Corticosteroid Creams Safe for Kids With Eczema: Study 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 3Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
AST (SGOT) R1 + R2. Automated analyzer test kits....
For the quantitative colorimetric determination of AST (SGOT) in serum....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Single vial, dry powder reagen...
Medicine Products: